Development of a serum vitellogenin MRM biomarker for determining sex in American eel (Anguilla rostrata)
开发用于确定美洲鳗(Anguilla rostrata)性别的血清卵黄蛋白原 MRM 生物标志物
基本信息
- 批准号:484149-2015
- 负责人:
- 金额:$ 1.82万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Engage Grants Program
- 财政年份:2015
- 资助国家:加拿大
- 起止时间:2015-01-01 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Sex determination in eels is not fixed as in humans and the ratio of males to females is subject to unknown
factors, such as environmental cues. Juvenile (glass/elvers) eels grown at commercial densities, were shown to
predominantly end up as males (95%). For commercial eel farming, female eels will reach desired market size
(>300 g), whereas males mature at a smaller size (<200 g) and do not achieve profitable market size. Success
of eel farming will depend on manipulating the sex ratio of eels to increase the proportion of females. Some
researchers have demonstrated sex manipulation in European and Japanese eels using ß-estradiol and other
estrogenic compounds. The difficulty in developing methods to manipulate sex in eels is that it is best to
change the sex in young eels (from 1 -30 g), but it is difficult to determine the sex of eels until they begin to
develop maturing gonads (80-150 g). This project intends to develop a cost-effective Liquid Chromatography -
Multiple Reaction Monitoring Mass Spectrometry (LC-MRM-MS/MS) method to develop a specific female
blood biomarker, vitellogenin, to determine sex in the American eel (Anguilla rostrata) at an earlier stage than
is observable by standard microscopic methods. LC-MRM-MS/MS methods will be carried out on blood, and
gonad samples from eels sampled in NovaEel's feminization trials. Vitellogenin is a protein synthesized in
oviparous animals that is made in the liver and carried in the blood to be delivered to the developing oocytes in
the ovaries. It has been used in other fish species as a marker for females. Data will be correlated and validated
with gonad development as determined by microscopic methods. Development of cost-effective methods to
feminize eels and to rapidly determine the sex of eels will help the company to develop commercially viable
eel farming in Eastern Canada.
鳗鱼的性别决定并不像人类那样固定,雄性与雌性的比例也是未知的。
比如环境因素。在商业密度下生长的幼鳗(玻璃/幼鳗)显示,
主要是男性(95%)。对于商业鳗鱼养殖,雌鳗将达到预期的市场规模
(>300 g),而雄性成熟时尺寸较小(<200 g),无法实现有利可图的市场规模。成功
鳗鱼养殖业的未来发展,将取决于操纵鳗鱼的性别比例,以增加雌性的比例。一些
研究人员已经证明了欧洲和日本鳗鱼的性别操纵使用β-雌二醇和其他
雌激素化合物开发操纵鳗鱼性别的方法的困难在于,
改变幼鳗的性别(从1 - 30 g),但直到它们开始
性腺发育成熟(80-150 g)。本项目旨在开发一种具有成本效益的液相色谱-
多反应监测质谱法(LC-MRM-MS/MS)用于开发特定的雌性动物
血液生物标志物,卵黄蛋白原,以确定性别在美国鳗鱼(Anguilla rostrata)在早期阶段比
可通过标准显微镜方法观察到。将对血液进行LC-MRM-MS/MS方法,
在NovaEel的雌性化试验中采集的鳗鱼性腺样本。卵黄蛋白原是一种蛋白质,
卵生动物,在肝脏中产生,并通过血液运送到发育中的卵母细胞,
卵巢它已被用于其他鱼类作为雌性的标记。将对数据进行关联和验证
通过显微镜方法确定性腺发育。制定具有成本效益的方法,
使鳗鱼雌性化并快速确定鳗鱼的性别将有助于该公司开发商业上可行的
加拿大东部的鳗鱼养殖业
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fawcett, James其他文献
Polyimide micro-channel arrays for peripheral nerve regenerative implants
- DOI:
10.1016/j.sna.2008.05.031 - 发表时间:
2008-10-03 - 期刊:
- 影响因子:4.6
- 作者:
Lacour, Stephanie P.;Atta, Raghied;Fawcett, James - 通讯作者:
Fawcett, James
Long Micro-Channel Electrode Arrays: A Novel Type of Regenerative Peripheral Nerve Interface
- DOI:
10.1109/tnsre.2009.2031241 - 发表时间:
2009-10-01 - 期刊:
- 影响因子:4.9
- 作者:
Lacour, Stephanie P.;Fitzgerald, James J.;Fawcett, James - 通讯作者:
Fawcett, James
Fawcett, James的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fawcett, James', 18)}}的其他基金
Polarity complexes in cellular differentiation
细胞分化中的极性复合物
- 批准号:
RGPIN-2022-03370 - 财政年份:2022
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Polarity complexes in cellular differentiation
细胞分化中的极性复合物
- 批准号:
RGPIN-2017-05146 - 财政年份:2021
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Polarity complexes in cellular differentiation
细胞分化中的极性复合物
- 批准号:
RGPIN-2017-05146 - 财政年份:2020
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Polarity complexes in cellular differentiation
细胞分化中的极性复合物
- 批准号:
RGPIN-2017-05146 - 财政年份:2019
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Polarity complexes in cellular differentiation
细胞分化中的极性复合物
- 批准号:
RGPIN-2017-05146 - 财政年份:2018
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Polarity complexes in cellular differentiation
细胞分化中的极性复合物
- 批准号:
RGPIN-2017-05146 - 财政年份:2017
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Polarity complexes in cellular differentiation
细胞分化中的极性复合物
- 批准号:
341898-2011 - 财政年份:2016
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Polarity complexes in cellular differentiation
细胞分化中的极性复合物
- 批准号:
341898-2011 - 财政年份:2014
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Polarity complexes in cellular differentiation
细胞分化中的极性复合物
- 批准号:
341898-2011 - 财政年份:2013
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Polarity complexes in cellular differentiation
细胞分化中的极性复合物
- 批准号:
341898-2011 - 财政年份:2012
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
相似国自然基金
组蛋白乙酰化对MSCs微环境适应性的调控作用及机制
- 批准号:30801234
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 1.82万 - 项目类别:
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 1.82万 - 项目类别:
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
- 批准号:
10750132 - 财政年份:2024
- 资助金额:
$ 1.82万 - 项目类别:
Investigation of Mergo? mechanism of action by quantitative serum protein profiling.
调查梅尔戈?
- 批准号:
10074412 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Collaborative R&D
Development of novel therapeutic approach using serum exosomes to conquer bone metastases from lung cancer
使用血清外泌体开发新的治疗方法来克服肺癌骨转移
- 批准号:
23K06704 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Project 2: Biomarker Analysis, Non-Genetic Risk Factors, and Their Genetic Interactions
项目 2:生物标志物分析、非遗传风险因素及其遗传相互作用
- 批准号:
10555697 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Creating an optimized and scalable production platform in suspension adapted serum-free HEK293 cells for rAAV gene delivery using a Design-of-Experime
使用实验设计在悬浮适应的无血清 HEK293 细胞中创建优化且可扩展的生产平台,用于 rAAV 基因递送
- 批准号:
2776049 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Studentship
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
- 批准号:
10367805 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes
使用模拟禁食饮食进行间歇性禁食以改善前列腺癌控制和代谢结果
- 批准号:
10639416 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别: